Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Radiology
MedTech
Lumexa Imaging IPO tallies $462.5M, doubling original target
Lumexa Imaging hauled in $462.5 million during its IPO, far exceeding the diagnostic services provider’s earlier target of $200 million.
Joseph Keenan
Dec 15, 2025 9:40am
Lumexa Imaging eyes IPO expected to raise $200M
Nov 19, 2025 12:28pm
Philips raises curtain on next-gen helium-sealed MRI scanner
Nov 21, 2024 3:00pm
GE HealthCare inks collab with RadNet in mammography AI
Nov 12, 2024 10:10am
GE HealthCare's PET tracer for heart disease nets FDA approval
Oct 1, 2024 12:00pm
Bayer taps Alara Imaging to enhance CT radiation dose monitoring
Aug 7, 2024 11:40am
